Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non‐Hodgkin's lymphoma

Non‐Hodgkin's lymphoma (NHL) has a wide biological heterogeneity and shows extremely variable responses to therapeutic measures. However, markers that indicate disease activity and determine treatment strategies for this malignancy are little recognized. Using the differential display method, w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2003-05, Vol.121 (3), p.439-447
Hauptverfasser:	Hamada, Makoto, Yakushijin, Yoshihiro, Ohtsuka, Masaki, Kakimoto, Miki, Yasukawa, Masaki, Fujita, Shigeru
Format:	Artikel
Sprache:	eng
Schlagworte:	aggressive non‐Hodgkin's lymphoma Aurora Kinase A Aurora Kinases Aurora2/BTAK/STK15 B-Lymphocytes - metabolism Biological and medical sciences Biomarkers, Tumor - analysis Blotting, Northern - methods cell cycle Cell Division - drug effects differential display Gene Expression Hematologic and hematopoietic diseases Hematology Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma, B-Cell - metabolism Lymphoma, B-Cell - therapy Medical sciences Oligonucleotides, Antisense - pharmacology Protein-Serine-Threonine Kinases - genetics Protein-Serine-Threonine Kinases - immunology Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - analysis Tumor Cells, Cultured tumorgenesis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!